Green Lifescience그린생명과학
114450 · KOSDAQ · ₩114450 · 그린생명과학
₩2,130▼ ₩30 (1.39%)End-of-day · Oct 28, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩40B | ₩25B | ₩22B | ₩37B | ₩25B |
| Cost of sales | ₩38B | ₩22B | ₩25B | ₩38B | ₩28B |
| Gross profit | ₩2.5B | ₩3B | −₩2.3B | −₩1.4B | −₩2.3B |
| Operating income | ₩204M | ₩377M | −₩4.6B | −₩4B | −₩4.6B |
| Net income | ₩110M | ₩1.6B | −₩16B | −₩3.5B | −₩3.1B |
| Net income to shareholders | ₩110M | ₩1.6B | −₩16B | −₩3.5B | −₩3.1B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩55B | ₩45B | ₩44B | ₩62B | ₩72B |
| Current assets | ₩33B | ₩22B | ₩22B | ₩26B | ₩27B |
| Cash and equivalents | ₩13B | ₩9.1B | ₩6.3B | ₩2.8B | ₩3.4B |
| Total liabilities | ₩17B | ₩9.2B | ₩7.9B | ₩9.8B | ₩16B |
| Current liabilities | ₩16B | ₩8.3B | ₩7.4B | ₩9.4B | ₩15B |
| Borrowings | ₩6.5B | ₩4.8B | ₩4.8B | ₩6.5B | ₩7.4B |
| Total equity | ₩38B | ₩36B | ₩36B | ₩53B | ₩56B |
| Shareholders' equity | ₩38B | ₩36B | ₩36B | ₩53B | ₩56B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩364M | ₩525M | ₩370M | −₩4.6B | ₩611M |
| Capital spending | ₩860M | ₩402M | ₩465M | ₩1.5B | ₩3.4B |
| Free cash flow | −₩496M | ₩123M | −₩95M | −₩6B | −₩2.8B |
| Dividends paid | — | — | — | — | ₩0 |
Consolidated where available. Amounts in won.
Also known as: Green Lifescience / 그린생명과학 / 114450 / KRX:114450
Source: KRX statistical information